Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance

Journal of Korean Medical Science

Volumn 23, Issue 3, 2008, Pages 556-559

  Sang, Yup Lim ^a   Ki, Seok Kim ^b   Seung, Jae Joo ^b   Myung, Ho Jeong ^c  

^a Korea University College of Medicine   (South Korea)

^b Jeju National University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Myocardial infarction; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; DRUG RESISTANCE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; RADIOGRAPHY; TIME;

AGED; ANGINA PECTORIS; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG RESISTANCE; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS;

EID: 46849097798     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.3.556     Document Type: Article

References (12)

1. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent trials. Circulation 2001; 103: 1967-71.
2. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions, Circulation 2007; 115: 2344-51.
3. Moreno R, Fernadez C, Hernadez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-9.
4. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. J Am Coll Cardiol 2005; 45: 941-6.
5. Ishikawa T, Mutoh M, Fuda Y, Sakamoto H, Okada H, Higashitani M, Nakano Y, Yamaguchi J, Enta K, Satoh T, Imai K, Horie T, Mochizuki S. Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction: a Japanese single center retrospective nonrandomized study. Circ J 2006; 70: 1091-2.
6. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-91.
7. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
8. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-9.
9. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautions? Circulation 2004; 109: 701-5.
10. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of Sirolimus eluting stent. Heart 2005; 91: e45.
11. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
12. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-53.